BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17378498)

  • 21. [The place of old and new beta-lactams in the therapy of infection].
    Angelescu M; Benea E
    Med Interna; 1991; 43(1-2):20-37. PubMed ID: 1670122
    [No Abstract]   [Full Text] [Related]  

  • 22. [beta-Lactam antibiotics].
    Goto H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():337-41. PubMed ID: 17455642
    [No Abstract]   [Full Text] [Related]  

  • 23. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
    [No Abstract]   [Full Text] [Related]  

  • 24. The versatile monobactam family: new agents addressing specific needs in infectious disease.
    Bonner DP; Koster WH
    J Chemother; 1989 Jul; 1(4 Suppl):133-4. PubMed ID: 16312338
    [No Abstract]   [Full Text] [Related]  

  • 25. Addressing the challenge of extended-spectrum beta-lactamases.
    Zahar JR; Lortholary O; Martin C; Potel G; Plesiat P; Nordmann P
    Curr Opin Investig Drugs; 2009 Feb; 10(2):172-80. PubMed ID: 19197795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
    Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-lactams with or without aminoglycosides.
    Alfandari S; Boussekey N
    Clin Infect Dis; 2005 Nov; 41(10):1542-3; author reply 1543-4. PubMed ID: 16231273
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-traditional beta lactams--carbapenems, penems and monocyclic antibiotics].
    Nazarov AD; Zhelaev AA
    Antibiot Khimioter; 1991 Apr; 36(4):42-7. PubMed ID: 1892435
    [No Abstract]   [Full Text] [Related]  

  • 29. Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.
    Hadley JA; Tillotson GS; Tosiello R; Echols RM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):923-37. PubMed ID: 17181408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?
    Roberts JA; Hope WW; Lipman J
    Int J Antimicrob Agents; 2010 May; 35(5):419-20. PubMed ID: 20189777
    [No Abstract]   [Full Text] [Related]  

  • 31. [Beta-lactam antibiotics].
    Rozmysłowicz T
    Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):757-61. PubMed ID: 2084633
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-lactams in the new millennium. Part-I: monobactams and carbapenems.
    Singh GS
    Mini Rev Med Chem; 2004 Jan; 4(1):69-92. PubMed ID: 14754445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The beta-lactam antibiotics].
    Rosin H
    Internist (Berl); 1989 Jan; 30(1):2-12. PubMed ID: 2646236
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms.
    Lesher MD; Hale CM; Wijetunge DSS; England MR; Myers DS; Craft DW
    Infect Control Hosp Epidemiol; 2020 May; 41(5):604-607. PubMed ID: 32248863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenems: do they have a future?
    Hamouda A; Findlay J; Amyes SGB
    J Med Microbiol; 2011 Sep; 60(Pt 9):1229-1230. PubMed ID: 21719576
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibacterial effect of beta-lactam antibiotics].
    Brändle HP; Hof H
    Med Klin (Munich); 1986 Feb; 81(4):125-9. PubMed ID: 3785067
    [No Abstract]   [Full Text] [Related]  

  • 37. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
    Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA
    Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance and administration of beta-lactam antibiotics in practice].
    Kienitz M
    Med Welt; 1982 Aug; 33(31-32):1102-4. PubMed ID: 7132655
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-lactam antibiotics are multipotent agents to combat neurological diseases.
    Ji HF; Shen L; Zhang HY
    Biochem Biophys Res Commun; 2005 Aug; 333(3):661-3. PubMed ID: 15907788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.